ARKG Holdings of Codexis (CDXS) - Updated Daily
Join Premium Plan
Key Statistics
Statistics
Clinical Trials (1)
Institutional Ownership Trends
News That Matters
๐ต๐ผFound In | ๐ทLast Price |
---|---|
ARKG | $20.21 |
โ๏ธWeighting | ๐งขMarket Cap |
2.21% | $1.32b |
๐๐ฟโโ๏ธWeight Rank In ARKG | ๐งฎPrice to Sales |
18 | 12.57 |
๐๏ธโโ๏ธWeight Rank Across All Funds | ๐Country |
50 | ๐บ๐ธUnited States |
๐ณARK Estimated Cost Average | ๐ซARK Ownership Percent |
$25.90 | 6.01% |
Description | |
---|---|
A protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food ingredients, to enable sequencing of minute quantities of DNA for medical diagnostics, and to create novel biotherapeutics. | |
Website | |
https://www.cedexis.com/ |
Research Notes and Commentary for CDXS
December 17, 2020
Daily Ark Digest
Trading Floor
December 15, 2020
Daily Ark Digest
Trading Floor